Smiths Detection Inc. news
Smiths Detection’s people and technology help to make the world a safer place. We do not do this alone, but together with our customers and partners who depend on our specialist equipment to screen for threats that may harm people or infrastructure.
Most of our customers are companies and organisations that play an essential role in their countries’ critical infrastructure and Smiths Detection needs to ensure that their equipment always remains reliable. So, during
Smiths Detection were recently awarded a prestigious Red Dot award for the intuitive design of the graphical user interface (GUI) of our computed tomography (CT) checkpoint scanner HI-SCAN 6040 CTiX.
Once a year the international Red Dot design competition awards excellence in the areas of product design, communication design, and design concepts.
CT systems
Smiths Detection Inc. (SDI) has announced it has successfully manufactured and shipped the 200th Computed Tomography (CT) 3-D Scanner from its Americas Headquarters located in Harford County, MD. The CT scanner marks a major milestone in advancing Transportation Security Administration’s (TSA) initiatives and is the result of SDI’s ongoing manufacturing during the COVID 19 crisis as part of the Defense Industrial Base essential critical infrastructure workforce.
In March 2
Smiths Detection today announces that it has partnered with Attomarker Ltd, a multiplex blood-testing technology company spun out of the University of Exeter, to help produce a robust and accurate COVID-19 antibody-testing device that could represent an evolution in rapid and precise COVID-19 antibody testing. The Medicines and Healthcare Products Regulatory Agency (MHRA) has already approved Attomarker’s Triple Antibody Test for NHS use in the UK.
The Smiths Detection team has
Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
The tests were performed using live SARS-CoV-2 virus in a Bio